alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 6,926–6,950 of 7,816 matching trials · page 278 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Valproate in Dementia (VALID)
NCT00071721
Valproate; Placebo
Runs in: United States · 46 sites 		PHASE3
other		 COMPLETED 313 Alzheimer's Disease Cooperative Study (ADCS)
OTHER		 2014-09-25
DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease
NCT00440050
DHA (Docosahexaenoic Acid); Placebo
Runs in: United States · 51 sites 		PHASE3
other		 COMPLETED 402 Alzheimer's Disease Cooperative Study (ADCS)
OTHER		 2014-09-25
A Study of Semagacestat for Alzheimer's Patients
NCT01035138
semagacestat
Runs in: Australia; Canada; Chile; Finland; France; Germany; Israe... · 71 sites 		PHASE3
other		 COMPLETED 180 Eli Lilly and Company
INDUSTRY		 2014-09-25
Minocycline in Patients With Alzheimer's Disease
NCT01463384
Minocycline
Runs in: United States · 1 site 		PHASE2
anti-inflammatory		 COMPLETED 13 Huntington Medical Research Institutes
OTHER		 2014-09-25
Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type
NCT02248116
Talsaclidine 		PHASE2|PHASE3
other		 TERMINATED 198 Boehringer Ingelheim
INDUSTRY		 2014-09-25
Cognitive Rehabilitation in Alzheimer's Disease
NCT02247180
cognitive rehabilitation; standardized cognitive training
Runs in: Germany · 1 site 		NA
other		 UNKNOWN 14 University of Rostock
OTHER		 2014-09-23
A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients
NCT01656525
Gantenerumab; Gantenerumab; Gantenerumab; Placebo
Runs in: Japan · 5 sites 		PHASE1
anti-amyloid-antibody		 COMPLETED 28 Chugai Pharmaceutical
INDUSTRY		 2014-09-19
Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's Disease
NCT02243982
[F18]-FDDNP
Runs in: Spain · 1 site 		EARLY_PHASE1
other		 COMPLETED 28 Fundacion Clinic per a la Recerca Biomédica
OTHER		 2014-09-18
Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea.
NCT01834053
autologous Stem Cell
Runs in: India · 1 site 		PHASE1|PHASE2
other		 UNKNOWN 50 Chaitanya Hospital, Pune
OTHER		 2014-09-17
ADNI: Alzheimer's Disease Neuroimaging Initiative
NCT00106899
Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET...
Runs in: Canada; United States · 59 sites 		NA
other		 COMPLETED 818 Alzheimer's Disease Cooperative Study (ADCS)
OTHER		 2014-09-16
Home-Based Assessment for Alzheimer Disease Prevention
NCT00546767
Mail and Live Phone; Interactive Voice Response (IVR); Home-based C...
Runs in: United States · 28 sites 		NA
other		 COMPLETED 640 Alzheimer's Disease Cooperative Study (ADCS)
OTHER		 2014-09-16
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
NCT01078636
Runs in: Canada; United States · 55 sites 		NA
other		 COMPLETED 342 Alzheimer's Disease Cooperative Study (ADCS)
OTHER		 2014-09-16
Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia
NCT00797277
IM olanzapine; IM haloperidol plus lorazepam
Runs in: Taiwan · 1 site 		PHASE3
other		 COMPLETED 67 National Taiwan University Hospital
OTHER		 2014-09-15
A Safety, Tolerability and Pharmacokinetics Study of JNJ-54861911 in Healthy Japanese Male Participants
NCT02180269
JNJ-54861911 (25 mg); JNJ-54861911 (50 mg); JNJ-54861911 (100 mg); Placebo
Runs in: Japan · 1 site 		PHASE1
other		 COMPLETED 24 Janssen Pharmaceutical K.K.
INDUSTRY		 2014-09-12
The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia
NCT02187276
cholinesterase inhibitors 		NA
symptomatic-cholinergic		 COMPLETED 129 Federal University of Minas Gerais
OTHER		 2014-09-12
Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease
NCT01028053
Flutemetamol (18F) Injection
Runs in: United States · 1 site 		PHASE3
other		 COMPLETED 365 GE Healthcare
INDUSTRY		 2014-09-11
Apathy Cure Through Bupropion in Huntington's Disease
NCT01914965
Bupropion; Placebo
Runs in: Germany · 2 sites 		PHASE2
other		 COMPLETED 40 Charite University, Berlin, Germany
OTHER		 2014-09-09
Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease
NCT00397891
bapineuzumab; bapineuzumab; bapineuzumab
Runs in: Japan · 4 sites 		PHASE1
anti-amyloid-antibody		 COMPLETED 80 Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY		 2014-09-04
A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies
NCT00598650
E2020 		PHASE2
other		 COMPLETED 160 Eisai Co., Ltd.
INDUSTRY		 2014-09-03
A Pilot Study of tDCS for Mild to Moderate Alzhemier's Disease
NCT02227953
Yband (YDT-201N); sham-Yband (YDT-201N)
Runs in: South Korea · 1 site 		NA
other		 UNKNOWN 20 Samsung Medical Center
OTHER		 2014-09-03
A Pilot Study of tDCS for Mild Cognitive Impairment
NCT02227966
Yband (YDT-201N); Sham-Yband (YDT-201N)
Runs in: South Korea · 1 site 		NA
other		 UNKNOWN 20 Samsung Medical Center
OTHER		 2014-09-03
Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment
NCT00684281
Neurological and neuropsychological consultation, MRI; Neurological...
Runs in: France · 1 site 		NA
other		 COMPLETED 60 Assistance Publique Hopitaux De Marseille
OTHER		 2014-08-28
Performance of AclarusDx® a Blood-Based Transcriptomic Test for AD, in French Patients Newly Referred to a Memory Center
NCT02221661 		NA
other		 COMPLETED 606 Diaxonhit
INDUSTRY		 2014-08-22
Study of STA-1 as an Add-on Treatment to Donepezil
NCT01255046
Donepezil,; STA-1; placebo
Runs in: Taiwan · 1 site 		PHASE2
symptomatic-cholinergic		 UNKNOWN 136 Sinphar Pharmaceutical Co., Ltd
OTHER		 2014-08-20
ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE
NCT01772095
Runs in: Greece · 1 site 		NA
other		 COMPLETED 389 Elpen Pharmaceutical Co. Inc.
INDUSTRY		 2014-08-19

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →